Life science companies are continuing to raise cash, keeping pace with the financing trends of recent years.
Fourth quarter figures are still being tallied but in the third quarter, 171 companies raised $3.2 billion, according to the Healthcare Moneytree report from PricewaterhouseCoopers and CB Insights. Those totals compare to 166 companies that raised $3.3 billion in the same period in 2016. Two years ago, the Moneytree report listed $3 billion raised from 210 deals in the third quarter.
On the first business day of 2018, several companies announced new rounds of financing to support new products coming to market or clinical… Read more »
UNDERWRITERS AND PARTNERS